Research Article
The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Nonfasting Remnant Cholesterol in a Real World Population
Figure 1
Change in remnant cholesterol levels from pretreatment to posttreatment by pretreatment triglyceride groups (error bars: 95% CI).
(a) |
(b) |
(c) |